Cloning, Sequencing, and the Expression of the Elusive Sarcomeric TPM4α Isoform in Humans.
Dipak K DubeSyamalima DubeLynn AbbottRuham Alshiekh-NasanyCharles MitschowBernard J PoieszPublished in: Molecular biology international (2016)
In mammals, tropomyosin is encoded by four known TPM genes (TPM1, TPM2, TPM3, and TPM4) each of which can generate a number of TPM isoforms via alternative splicing and/or using alternate promoters. In humans, the sarcomeric isoform(s) of each of the TPM genes, except for the TPM4, have been known for a long time. Recently, on the basis of computational analyses of the human genome sequence, the predicted sequence of TPM4α has been posted in GenBank. We designed primer-pairs for RT-PCR and showed the expression of the transcripts of TPM4α and a novel isoform TPM4δ in human heart and skeletal muscle. qRT-PCR shows that the relative expression of TPM4α and TPM4δ is higher in human cardiac muscle. Western blot analyses using CH1 monoclonal antibodies show the absence of the expression of TPM4δ protein (~28 kDa) in human heart muscle. 2D western blot analyses with the same antibody show the expression of at least nine distinct tropomyosin molecules with a mass ~32 kD and above in adult heart. By Mass spectrometry, we determined the amino acid sequences of the extracted proteins from these spots. Spot "G" reveals the putative expression of TPM4α along with TPM1α protein in human adult heart.
Keyphrases
- poor prognosis
- endothelial cells
- skeletal muscle
- amino acid
- mass spectrometry
- heart failure
- binding protein
- pluripotent stem cells
- atrial fibrillation
- metabolic syndrome
- gene expression
- left ventricular
- type diabetes
- long non coding rna
- high resolution
- adipose tissue
- room temperature
- hypertrophic cardiomyopathy
- ms ms
- protein protein
- genetic diversity
- bioinformatics analysis